Chemfab Alkalis DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.08×17.13×22.73×0.67×0.72×
1.24×0.17×−0.04×1.24×1.02×
−1.2%−0.4%2.2%9.6%26.4%
0.57×0.57×0.65×0.72×0.87×
1.54×1.54×1.37×1.29×1.14×
−0.1%−1.0%−1.9%7.5%19.3%
−0.9%−0.9%−1.8%7.0%19.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CHEMFAB₹293.75

Chemfab Alkalis Limited

· Chemicals
₹ CrorePeersPRIMOPLASTIBLENMANORGKRONOXJAYAGROGNLORDSCHLODMCCSRHHYPOLTDMcap ₹422 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.720.6722.7317.130.08
Interest Burden (Pretax/EBIT) ×1.021.24-0.040.171.24
EBIT Margin %26.429.642.21-0.39-1.19
Asset Turnover ×0.870.720.650.570.57
Financial Leverage (Assets/Equity) ×1.141.291.371.541.54
ROE (5-step product, year-end total equity) %19.347.48-1.85-0.96-0.10
ROE (owners' profit / average owners' equity) %19.597.03-1.81-0.91-0.91
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.